A long tradition of Success
1920
Wilhelm Haselmeier GmbH & Co is founded in Stuttgart-Degerloch, Germany.
The company specialized in the development and supply of glass syringes, special syringes, stethoscopes and products for diagnostics.
1963
Haselmeier developed and produced a semi-automated autoinjector for glass insulin syringes. Haselmeier is the first company to introduce an autoinjector.
1978
Haselmeier enters the Diabetes market with the development and supply of Diamatic, a fully automatic autoinjector for disposable insulin syringes.
The production is moved to a new factory in Buchen im Odenwald, Germany.
1993
Haselmeier expands its pen franchise with the development and supply of a fully automatic insulin pen with hidden needle.
1998
Haselmeier develops the Penlet, a fixed dose, multiple injections disposable autoinjector for low molecular weight heparin.
2001
Haselmeier develops and supplies a fully automatic pen injector with hidden needle for growth hormone. The one.click™ - based on this platform - is exclusively launched by Serono, today Merck Serono.
2002
Haselmeier establishes a manufacturing site in Dnesice (Czech Republic) for metal turning and for pen assembly.
2003
Haselmeier develops and supplies a new pen injector for insulin therapy that incorporates 3ml cartridges. The DIAPEN® - based on this platform - is launched in Germany.
2004
Haselmeier establishes a U.S. office in Severna Park MD (Unites States).
2005
The BerliPen® areo 1 is launched by Berlin-Chemie in Germany, as a reusable pen for insulin therapy. This pen offers state-of-the-art design and function.
2008
Haselmeier establishes its International Sales and Marketing office in Zürich, Switzerland.
The BerliPen® areo 2 is launched in Germany and offers significant function and design improvements over the previous version.
2009
Haselmeier opens a representation office in Gurgaon, India and expands its manufacturing site in the Czech Republic.
2010
Haselmeier opens a new manufacturing site in the Czech Republic in the first quarter of 2010.
Haselmeier today
Haselmeier has been active in the medical device field for almost 90 years and has locations on 3 continents in 5 countries.
With a large number of patents, Haselmeier satisfies a wide range of customer needs.
Haselmeier is offering experience, competence and expertise in:
- The development/production of pen- and autoinjectors for self-administration of medicines through subcutaneous injection
- Custom design and production of medical devices
- Product design in simultaneous engineering to optimize the development and production processes
- Quality Management System to guarantee a cost effective, consistent and high quality product